Connecting you to content on EBSCOhost

Works matching AU Behling, F

Results: 5

1

P.157 TERT expression predicts progression-free survival in meningiomas.

Published in:

2025

By:

Gui, C;
Wang, JZ;
Patil, V;
Landry, AP;
Castelo-Branco, P;
Tabori, U;
Behling, F;
Aldape, K;
Barnholtz-Sloan, JS;
Horbinski, CM;
Tabatabai, G;
Ajisebutu, A;
Liu, J;
Patel, Z;
Yakubov, R;
Kaloti, R;
Ellenbogen, Y;
Wilson, C;
Cohen-Gadol, A;
Tatagiba, M

Publication type:

Abstract

2

P.142 Development and validation of a molecular classifier of meningiomas.

Published in:

2025

By:

Landry, A;
Wang, J;
Liu, J;
Patil, V;
Gui, C;
Ajisebutu, A;
Ellenbogen, Y;
Cohen-Gadol, A;
Tabatabai, G;
Tatagiba, M;
Behling, F;
Barnholtz-Sloan, J;
Sloan, A;
Chambless, L;
Rebchuk, A;
Makarenko, S;
Yip, S;
Mansouri, A;
Tsang, D;
Aldape, K

Publication type:

Abstract

3

F.1 Validation and next-generation update of a DNA methylation-based recurrence predictor for meningioma: a multicenter prospective study.

Published in:

2025

By:

Landry, A;
Wang, J;
Patil, V;
Gui, C;
Yasin, M;
Ajisebutu, A;
Ellenbogen, Y;
Cohen-Gadol, A;
Tabatabai, G;
Tatagiba, M;
Behling, F;
Sloan, J;
Sloan, A;
Chambless, L;
Mansouri, A;
Ehret, F;
Capper, D;
Tsang, D;
Aldape, K;
Gao, A

Publication type:

Abstract

4

Low FoxG1 and high Olig‐2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)‐mutant gliomas.

Published in:

Neuropathology & Applied Neurobiology, 2018, v. 44, n. 2, p. 207, doi. 10.1111/nan.12447

By:

Schäfer, S.;
Behling, F.;
Skardelly, M.;
Koch, M.;
Ott, I.;
Paulsen, F.;
Tabatabai, G.;
Schittenhelm, J.

Publication type:

Article

5

F.3 Comprehensive multiplatform analysis of CDKN2A alterations in meningiomas.

Published in:

2023

By:

Wang, JZ;
Patil, V;
Liu, J;
Dogan, H;
Tabatabai, G;
Behling, F;
Hoffman, E;
Bunda, S;
Yakubov, R;
Kaloti, R;
Brandner, S;
Gao, A;
Cohen-Gadol, A;
Barnholtz-Sloan, J;
Skardelly, M;
Tatagiba, M;
Raleigh, D;
Sahm, F;
Boutros, PC;
Aldape, K

Publication type:

Abstract